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Objective: Ischemia-reperfusion (IR) injury is a signiﬁcant problem in the management of patients with acute limb
ischemia. Despite rapid restoration of blood ﬂow after technically successful open and endovascular revascularization,
complications secondary to IR injury continue to occur and limit clinical success. Our aim was to create a murine model of
hind limb IR injury to examine the role of Toll-like receptor-4 (TLR4) and to determine whether inactive TLR4 led to
a decrease in the detection of neutrophil extracellular traps (NETs), which are known to be highly thrombogenic and may
mediate microvascular injury.
Methods: A calibrated tension tourniquet was applied to unilateral hind limb of wild-type (WT) and TLR4 receptor
mutant (TLR4m) mice for 1.5 hours to induce ischemia and then removed to initiate reperfusion. At the end of 48 hours
of reperfusion, mice were euthanized and hind limb tissue and serum specimens were collected for analysis. Hematoxylin
and eosin-stained sections of hind limb skeletal muscle tissue were examined for ﬁber injury. For immunohistochemistry,
mouse monoclonal antihistone H2A/H2B/DNA complex antibody to detect NETs and rabbit polyclonal anti-
myeloperoxidase antibody were used to identify inﬁltrating cells containing myeloperoxidase. Muscle adenosine
triphosphate levels, nuclear factor (NF)-kB activity, the a-subunit of inhibitor of NF-kB light polypeptide gene enhancer,
poly (adenosine diphosphate-ribose) polymerase activity, and inducible nitric oxide synthase expression were measured.
Systemic levels of keratinocyte-derived chemokine, monocyte chemotactic protein-1, and vascular endothelial growth
factor in the serum samples were also examined.
Results: IR injury in the hind limb of WT mice demonstrated signiﬁcant levels of muscle ﬁber injury, decreased energy
substrates, increased NF-kB activation, decreased levels of a-subunit of inhibitor of NF-kB light polypeptide gene
enhancer, increased inducible nitric oxide synthase expression, and increased poly (adenosine diphosphate-ribose) poly-
merase activity levels compared with the TLR4m samples. Additionally, there was marked decrease in the level of
neutrophil and monocyte inﬁltration in the TLR4m mice, which corresponded to similar levels of decreased NET
detection in the interstitial space and in microvascular thrombi. In situ nuclease treatment of WT tissue sections
signiﬁcantly diminished the level of NET immunostaining, demonstrating the speciﬁcity of the antibody to detect NETs
and suggesting a potential role for nuclease treatment in IR injury.
Conclusions: These results suggest a pivotal role for TLR4 in mediating hind limb IR injury and suggest that NETs may
contribute to muscle ﬁber injury. (J Vasc Surg 2013;58:1627-36.)
Clinical Relevance: Ischemia-reperfusion (IR) injury is a major problem in the treatment of peripheral vascular disease.
To better understand its mechanism, a murine model of hind limb IR injury was created in Toll-like receptor-4 mutant
mice. Results showed that mutant mice demonstrated signiﬁcantly less IR-related injury compared with the wild-type
mice. In addition, there was marked decrease in the level of neutrophil extracellular trap detection in the interstitial
tissue and in vessels of the hind limb. These results indicate that Toll-like receptor-4 is a key player in murine hind limb IR
injury and that systemic nuclease treatment may potentially ameliorate IR injury.the Divisions of Vascular Imaging and Interventiona and Vascular and
dovascular Surgery,b Harvard Medical School, Massachusetts General
ospital.
.W. is the Isenberg Scholar in Academic Surgery at the Massachusetts
eneral Hospital. This study was supported by National Institutes of
ealth Grant RO1-AR-055843 (M.T.W.), the Paciﬁc Vascular Research
undation, and the Department of Surgery, Division of Vascular and
dovascular Surgery (The Rosenberg Fund). R.O. is funded by the
merican College of Phlebology and the Department of Radiology, Divi-
n of Vascular Imaging and Intervention.
Author conﬂict of interest: none.
Reprint requests: Michael T. Watkins, MD, Massachusetts General
Hospital, Division of Vascular and Endovascular Surgery, 15 Parkman
St, Ste 440, Boston, MA 02114 (e-mail: mtwatkins@partners.org).
The editors and reviewers of this article have no relevant ﬁnancial relationships
to disclose per the JVS policy that requires reviewers to decline review of any
manuscript for which they may have a conﬂict of interest.
0741-5214/$36.00
Copyright  2013 by the Society for Vascular Surgery.
http://dx.doi.org/10.1016/j.jvs.2013.02.241
1627
JOURNAL OF VASCULAR SURGERY
1628 Oklu et al December 2013The cornerstone for the treatment of acute limb
ischemia is to rapidly restore blood ﬂow to the limb to
minimize ischemia-reperfusion (IR) injury, which occurs
when blood is reintroduced into the oxygen-deprived
limb. The mechanism of reperfusion injury is complex,
involving a vigorous inﬂammatory response to reﬂow in
which the innate immune system plays a central role. IR
injury is in part mediated by proinﬂammatory cytokines,
endothelial cell activation, reactive oxygen species, and
neutrophil inﬁltration and activation. There is growing
evidence linking the Toll-like receptor (TLR) family of
proteins of the innate immune system, speciﬁcally TLR4,
and the development of IR injury in myocardial infarction,
stroke, intestinal ischemia, transplantation, and sepsis.1-4
The role of TLR4 in IR has been largely derived from
murine models deﬁcient in the functional form of the
TLR4 gene. Deﬁciency of TLR4 provides signiﬁcant pro-
tection from tissue injury in hepatic transplant models
and in murine models of cardiac, cerebral, and renal IR
and hemorrhagic shock.1,4-7
Neutrophils play a key role in the inﬂammatory re-
sponse raised against IR injury. The accumulation of
neutrophils into an inﬂamed site is directed by cytokines
and, upon activation, neutrophils can release neutrophil
extracellular traps (NETs), which consist of neutrophil
genomic DNA studded with cytoplasmic granular proteins
released into the extracellular matrix.8 Although NETs
were initially detected in infectious tissues, such as in appen-
dicitis, shigellosis, fasciitis, and pneumonia, they have also
been detected in plasma and thrombus.9-11 In infection,
NETs seem to have a protective, antimicrobial effect. In
thrombosis, however, NETs appear to have a deleterious
effect by playing a role in clot formation directly by stim-
ulating platelets via the TLR4 pathway.3,9,12,13
This study designed experiments to test the hypothesis
that TLR4 modulates skeletal muscle injury, inﬂamma-
tion, and the production of NETs in response to IR. To
test this hypothesis, murine hind limb IR injury was
created in wild-type (WT) and TLR4 mutant (TLR4m)
mice. Several factors were examined to assess structural
muscle damage (histologic examination), skeletal muscle
energy metabolism (adenosine triphosphate [ATP]), and
markers of inﬂammation (inducible nitric oxide synthase
[iNOS] messenger RNA [mRNA], poly [adenosine
diphosphate (ADP)-ribose] polymerase [PARP] activity),
expression of p65 nuclear factor (NF)-kB protein, and
the a-subunit of the inhibitor of NF-kB protein (I-kBa),
systemic inﬂammation (serum cytokines), and angiogen-
esis (serum vascular endothelial growth factor [VEGF]).
Lastly, the detection of NETs within the injured hind
limb was examined using immunohistochemistry to deter-
mine whether the functional status of TLR4 was associ-
ated with the amount of NETs detected and the level of
tissue injury.
METHODS
Animal care and experimental procedures were in
compliance with the “Principals of Laboratory AnimalCare” (Guide for the Care and Use of Laboratory Animals,
U.S. National Institutes of Health publication No. 85-23,
National Academy Press, Washington, D.C., revised 1996)
and approved by the Institutional Review Committee.
Animal protocols. C3H/HeJ TLR4m14 and WT
C3H/HeSnJ mice (8 to 12 weeks old; The Jackson
Laboratory, Bar Harbor, Me) were housed in pathogen-
free cages and given free access to water and standard
rodent chow. As previously described, 1.5 hours of hind
limb ischemia, followed by reperfusion, was created.15
After 48 hours of reperfusion, mice were euthanized and
hind limb tissue and serum specimens were collected. Hind
limbs were ﬁxed for histologic analysis or immediately
frozen in liquid nitrogen and stored at 80C for future
analysis.
HISTOLOGY AND IMMUNOHISTOCHEMISTRY
Muscle injury. Transverse 5-mm sections of hind limb
muscle tissue were stained with hematoxylin and eosin
(H&E) to visualize tissue morphology. To determine
muscle ﬁber injury in each of the hind limb specimens
(WT, n ¼ 8; TLR4m, n ¼ 8), 16 images from the H&E
stained sections (original magniﬁcation, 200) of the ante-
rior tibialis and gastrocnemius muscle groups were ob-
tained using a light microscope after 48 hours of
reperfusion. Each image was assigned a distinct number
using SPOT Insight microscope camera software (Diag-
nostic Instruments, Sterling Heights, Mich) and analyzed
as previously described.16 Muscle ﬁber injury was indi-
cated by the presence of destroyed cell membrane, loss of
nuclear morphology, and loss of polygonal shape of the
muscle ﬁber. The data were expressed as the percentage of
injured ﬁbers from the total number of muscle ﬁbers
counted in each tissue sample, as previously described.16
Inﬂammatory cell inﬁltration. Because myeloperox-
idase (MPO) is produced by neutrophils and macro-
phages,17,18 tissue sections were immunostained for this
protein (WT, n ¼ 8; TLR4m, n ¼ 8). Rabbit polyclonal
anti-MPO (Abcam, Cambridge, Mass) was used for
detection at a concentration of 1 mg/mL. The secondary
antibody, antirabbit immunoglobulin G (IgG) conjugated
to horseradish peroxidase enzyme (Vector Labs, Burlin-
game, Calif), was also used in the same concentration.
Sections were developed using 3,30-diaminobenzindine
chromogen reagent solution (R&D Systems, Minneapolis,
Minn) according to the manufacturer’s instructions. A Carl
Zeiss microscope (100TV; Carl Zeiss Microimaging,
Thornwood, NY) with a multiband ﬁlter block was used to
visualize the tissue sections. Images of these sections were
taken using a Quantiﬁre X1 digital camera (Optronics,
Goleta, Calif) and processed using Pictureframe software
(Optronics). For negative controls, the MPO antibody was
substituted with 1 mg/mL dilution of the antirabbit IgG.
Similar to the quantitation of the muscle ﬁber assay,
20 images at original magniﬁcation 200 for each hind
limb muscle tissue section immunostained for MPO were
assigned a number using a random number generator.
Sixteen of the 20 images from each hind limb tissue
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Jose, Calif), and a blinded reviewer counted all MPO-
positive cells. The data are expressed as mean number of
MPO-positive cells/high-power ﬁeld (HPF; original
magniﬁcation 200) 6 standard error for each group.
NET detection. Hind limb tissue sections (WT,
n ¼ 8; TLR4m, n ¼ 8) were developed using a cyanine-
3 tyramide signal ampliﬁcation kit (PerkinElmer Life,
Boston, Mass) according to the manufacturer’s in-
structions. The mouse monoclonal antihistone H2A/
H2B/DNA complex antibody (gift of Dr Marc Monestier,
Temple University, Pa) and the antimouse IgG antibody
(Vector Labs) were used to detect NETs at 1 mg/mL
dilution.19 Sections for immunoﬂuorescence were mount-
ed using Vectashield mounting medium (Vector Labs)
containing 4,06-diamidino-2-phenylindole. As above, a
Carl Zeiss microscope (100TV) was used to image the
immunoﬂuorescent slides. For negative control, the NET
antibody was omitted and substituted with 1 mg/mL
dilution of the antimouse IgG. To demonstrate the speci-
ﬁcity of the mouse monoclonal antihistone H2A/H2B/
DNA complex antibody to detect NETs, a subset of tissue
sections were initially treated with 10 units of DNase
enzyme (New England BioLabs, Ipswich, Mass) for 30
minutes at 37C. These sections were not treated with
Triton X-100 to minimize permeabilization.
Muscle ATP quantitation. Two hundred milligrams
of each frozen hind limb muscle tissue (WT, n ¼ 5;
TLR4m, n ¼ 5) was homogenized on ice in 10% trichloro-
acetic acid using a polytron tissue disruptor. The superna-
tant from each sample was collected after centrifugation
for 10 minutes at 10,000g at 4C. Each sample was
diluted using Dulbecco’s modiﬁed phosphate-buffered
saline (with Ca2þ and Mg2þ, pH, 7.4). ATP levels
(nmol/mg tissue) were measured using the ATPlite
luminescence assay (PerkinElmer Life), following the
manufacturer’s instructions.
NF-kB activity. Total nuclear protein extracts were
prepared from fresh hind limb tissue (WT, n ¼ 5;
TLR4m, n ¼ 5) using a nuclear extraction kit (Active
Motif, Carlsbad, Calif), following the manufacturer’s
instructions. Brieﬂy, tissue (200 mg) was trimmed from
the posterior calf muscle, rinsed in ice cold phosphate-
buffered saline, and immediately homogenized in a hypo-
tonic buffer supplemented with 1 mL of a detergent mix
and 1 mL/mL of 1M dithiothreitol. The homogenate was
placed on ice for 30 minutes and centrifuged for 10
minutes at 850g at 4C. The pellet was resuspended in
a hypotonic buffer, and 50 mL/mL of detergent was added
for each milliliter of total volume and then mixed and
centrifuged for 30 seconds at 14,000g. The supernatant
was decanted and the pellet resuspended in a lysis buffer.
Samples were rocked on ice for 30 minutes and centrifuged
for 10 minutes at 14,000g at 4C. The supernatant was
collected, and aliquots were stored at 80C until analysis.
The concentration of the proteins was determined
using a bicinchoninic acid assay with bovine serum albumin
as the standard (Pierce Biotechnology, Rockford, Ill),following the manufacturer’s instructions. To estimate
NF-kB activation in the hind limb tissues, a Trans-AM
NF-kB p65 Transcription Factor Assay Kit (Active Motif,
Carlsbad, Calif) was used, following the manufacturer’s
instructions. The assay used 20 mg of each of the nuclear
protein samples. Results are presented as a mean optical
density 450 nm 6 standard error of the mean.
IkBa expression and PARP activity. One hundred
micrograms of total protein isolated from each hind limb
tissue (WT, n ¼ 5; TLR4m, n ¼ 5) was solubilized with
equal volume of Laemmli sample buffer (0.25M Tris-
HCl [pH 6.8], 8% sodium dodecyl sulfate, 40% glycerol,
0.4M dithiothreitol, and 0.04% Bromophenol Blue; Bio-
Rad, Hercules, Calif), boiled for 5 minutes, and then
loaded onto lanes at 4% to 15% density gradient on
Tris-HCl sodium dodecyl sulfate-polyacrylamide gel.
Samples were subjected to electrophoresis, followed by
electroblotting transfer using a 0.22-mm nitrocellulose
membrane (BioRad). The membranes were blocked with
Western blot blocker (Sigma-Aldrich, St. Louis, Mo) for 1
hour at room temperature. To assess PARP activity, the
membranes were incubated with monoclonal anti-PARP
antibody (1:2000 dilution, Tulip Biolabs, West Point, Pa)
that detects PARP-modiﬁed proteins in the muscle extracts.
To determine the level of total and phosphorylated
IkBa, membranes were incubated with polyclonal rabbit
anti-IkBa antibody or polyclonal rabbit antiphosphor-
IkBa (pSer32) antibody (1:1000 dilution for both anti-
bodies; Cell Signaling Technology, Danvers, Mass) for 1
hour at room temperature. Membranes were probed with
goat antimouse or goat antirabbit horseradish peroxidase-
conjugated IgG (1:4000 dilution) in blocking buffer for
1 hour at room temperature. The membranes were washed
and developed using the enhanced chemiluminescence
detection system (GE Healthcare, Piscataway, NJ). The
generated speciﬁc protein band integrated density values
(IDVs) were measured using the FluorChem HD2 Imager
system (Cell Biosciences, Santa Clara, Calif). The mem-
branes were stripped and reprobed using antimouse a-
tubulin IgG (Abcam).
iNOS mRNA expression
Semi-quantitative reverse transcription-polymerase
chain reaction. Total RNA was isolated from hind-limb
tissue (WT, n ¼ 5; TLR4m, n ¼ 5) after homogeniza-
tion in Trizol Reagent (Invitrogen, Carlsbad, Calif), fol-
lowed by chloroform phase separation and 2-propanol
precipitation. Total RNA samples were puriﬁed by silica gel
membrane column (Qiagen, Valencia, Calif). The
concentration of total RNA was determined by measuring
the absorption at 260 nm, and the purity of the puriﬁed
RNA was assessed by the ratio between the absorbance
values at 260 and 280 nm. Equal amounts of total RNA
were reverse-transcribed using the SuperScript First-Strand
Synthesis System (Invitrogen) and Oligo (dT) primers.
iNOS complementary DNA was ampliﬁed using platinum
blue polymerase chain reaction super mix as follows: 94C
for 30 seconds, 55C for 30 seconds, and 72C for 60
Fig 1. Representative images are shown of hematoxylin and eosin staining of the murine hind limb muscle tissue
sections after 1.5 hours of ischemia and 48 hours of reperfusion. A, Tissue sections from Toll-like receptor-4 mutant
(TLR4m) mice show relatively preserved muscle ﬁbers with scattered ﬁber injury (black arrows) and tissue edema (black
bar ¼ 100 mm). B, Wild-type (WT) tissue sections show signiﬁcantly greater muscle ﬁber injury, with black arrows
indicating examples of injured ﬁbers (black bar ¼ 100 mm). C, There was signiﬁcantly greater muscle ﬁber injury in the
WT hind limb muscle groups, gastrocnemius, and anterior tibialis, compared with the TLR4m tissues (*P < .05, **P <
.01, respectively). D, Increased muscle ﬁber injury in WT mice was consistent with signiﬁcantly decreased adenosine
triphosphate (ATP) levels compared with the less injured TLR4m group showing much higher ATP levels (*P < .04).
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for iNOS were previously described.20 The following
b-actin primers were used:
50-CAGGTCATCACTATTGGCAACG-30 and
50-CACAGAGTACTTGCGCTCAGGA-30 for 26 cycles.
The reaction mix of each sample was subjected to 1.5%
agarose electrophoreses in TAE (Tris base, acetic acid, and
ethylenediaminetetraacetic acid) buffer. Alpha Imager
1000 system (Alpha Innotech Corp, San Leandro, Calif)
was used to calculate the bands IDVs after background
correction.Data were normalized to b-actin band densities.
Serum cytokines and VEGF. Serum aliquots (WT,
n ¼ 8; TLR4m, n ¼ 8) obtained after 48 hours of reper-
fusion were assayed for keratinocyte-derived cytokine
(KC), monocyte chemoattractant protein-1 (MCP-1),
and vascular endothelial growth factor (VEGF) using
quantitative enzyme-linked immunosorbent assay (R&D
Systems), according to the manufacturer’s protocol.
Statistical analysis. Statistical analysis between two
groups was performed with Instat software (GraphPad,
San Diego, Calif) using parametric and nonparametric
unpaired t-tests. The results are expressed as the mean 6
standard error.
RESULTS
Muscle ﬁber injury. Muscle ﬁber injury in the WT
group was signiﬁcantly greater than in the TLR4m samples(WT, 45.5% 6 9% vs TLR4m, 15.8% 6 6% injured ﬁbers;
n ¼ 8/group; P < .03; Fig 1, C) indicating that inactive
TLR4 receptor signaling preserves muscle ﬁber integrity
during IR. Representative photomicrographs of the re-
perfused skeletal muscle in TLR4m and WT are demon-
strated in Fig 1, A and B, respectively. There were no
differences in skeletal muscle morphology between non-
ischemic sham-operated WT and TLR4m mice (data not
shown).
MPO immunostaining of reperfused skeletal
muscle. Quantitative analysis of MPO immunostaining of
reperfused skeletal muscle from WT and TLR4m mice
showed signiﬁcantly more MPO-positive cells in the WT
mice (245 6 28 cells/HPF) than in the TLR4m mice
(53 6 17 cells/HPF; n ¼ 8/group; P < .0001; Fig 2).
These inﬁltrates were more prominent in the interstitial and
perivascular regions of WT (Fig 2, B) than in the TLR4m
mice (Fig 2, A). The tissue sections of the contralateral
hind limbs not subjected to IR showed no evidence of
MPO-positive immunostaining.
Expression of NETs in reperfused skeletal muscle.
Regions demonstrating increased cell density that were
positive for the MPO marker also revealed intense immu-
nostaining for NETs (Fig 3). More NETs were detected
in the WT group (Fig 3, A) than in the TLR4m group
(Fig 3, B), mirroring the level of neutrophil detection
by MPO (Fig 2). NETs were found largely in the
Fig 2. A, Representative images are shown of immunohistochemical detection of myeloperoxidase (MPO) in murine
hind limb muscle tissue sections after 1.5 hours of ischemia and 48 hours of reperfusion (black bar ¼ 100 mm). B,
Immunostaining of specimens from Toll-like receptor-4 mutant (TLR4m) mice showed signiﬁcantly less MPO-positive
cells (brown) in muscle tissue than the wild-type (WT) group. The black arrows indicate examples of MPO-positive cells
(black bar¼ 100 mm). C, There were more than ﬁvefold greater MPO immunostained cells within the tissue sections of
WT mice compared with the TLR4m mice (*P < .0001).
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cular thrombi. The amount of NET immunostaining was
signiﬁcantly lower in sections from the TLR4m mice and
was undetectable tissue sections from the control contra-
lateral hind limb (Fig 3, C), providing evidence that the
origin of these NETs is predominantly the neutrophils.
To explore the possibility of using DNase as a potential
therapeutic agent to degrade the NETs and to demonstrate
the speciﬁcity of the antibody to detect NETs, WT tissue
sections were immunostained for NETs after DNase treat-
ment. The immunoﬂuorescent images revealed a marked
decrease in the detection of NETs in the interstitial, peri-
vascular, and microvascular thrombi of the WT sections
after DNase treatment (Fig 4).
Biochemical characterization of reperfused skeletal
muscle
Expression of iNOS mRNA. TLR4m mice had sig-
niﬁcantly less iNOS expression than WT mice at 48 hours
(n ¼ 5/group; P < .03; Fig 5). This ﬁnding suggests that
TLR4 modulates expression of iNOS in skeletal muscle
during hind limb IR injury.
Adenosine triphosphate. TLR4m samples contained
signiﬁcantly higher levels of ATP than WT samples after
IR (TLR4m: 2.1 6 0.4 vs WT: 1.06 6 0.3 nmol/mg
tissue; n ¼ 5/group; P ¼ .04; Fig 1, D). This ﬁnding
further suggests that in the absence of functional TLR4,
there are preserved levels of ATP consistent with decreased
levels of muscle ﬁber injury, as demonstrated by histology.
NF-kB activity and IkBa expression. To estimate
the level of NF-kB activation in the hind limb tissues of
the WT and the TLR4m groups, nuclear extracts were
assayed, revealing signiﬁcant differences after 1 hour ofreperfusion. The relative activation of the p65 subunit of
NF-kB in the TLR4m group was signiﬁcantly less than
the WT mice (TLR4m, 0.7342 6 0.05 vs 1.145 6 0.11
AU; n ¼ 5/group; P < .01; Fig 6, A). Thus, the acute
activation of the transcription factor NF-kb was markedly
decreased in the TLR4m group compared with the WT
mice. At 48 hours of reperfusion, however, p65 NF-kb
activity was not signiﬁcantly different between the two
groups (TLR4m, 0.59 6 0.1 vs 0.53 6 0.09 AU; P < .69;
Fig 6, A), suggesting that there may be an overlap between
other cell receptor signaling pathways.
To further support the idea that the initial NF-kb acti-
vation is markedly decreased in TLR4m mice, Western
blotting analysis showed that the expression of the total
IkBa subunit protein was signiﬁcantly elevated in the
hind limb muscle tissue of the TLR4m mice compared
with the WT mice at 1 hour of reperfusion (TLR4m:
28761 6 2282 vs WT: 16934 6 1493 IDV; P < .003;
Fig 6, B and C). The quantity of phosphorylated IkBa
protein, however, was not signiﬁcantly different between
the two groups (TLR4m: 9456 6 1987, WT: 4992 6
3382 IDV; P < .06; Fig 6, B and C).
PARP activity. TLR4m mice showed a signiﬁcant
decrease in the PARP-modiﬁed proteins at 48 hours’
reperfusion compared with WT (3.86 6 0.87 for TLR4 vs
8.1 6 1.6 IDV ratio; n ¼ 5/group; P ¼ .03; Fig 6, D and
E). These data suggest that modiﬁcation of PARP has been
reduced in TLR4m, which implicates a link between PARP
activity and TLR4 signaling pathway activity during skeletal
muscle reperfusion injury.
Systemic markers of inﬂammation. CXC/KC
(neutrophil chemokine), MCP-1, and VEGF levels in the
serum samples of WT were compared with TLR4m
Fig 4. Immunoﬂuorescent images show neutrophil extracellular traps (NETs) in red and nuclear DNA in blue in wild-
type tissue section with and without DNase treatment. A, Wild-type (WT) tissue section demonstrates detection of
NETs in a thrombosed vein (arrowhead) and in the interstitium (arrows). B, Adjacent tissue section was immuno-
stained for NETs after an initial incubation with DNase enzyme. The section shows signiﬁcant decrease in NET signal,
suggesting that nuclease pretreatment markedly reduced the level of antigen available for detection. The white bar in
each image represents 80 mm.
Fig 3. Representative images are shown for immunostaining for neutrophil extracellular traps (NETs) in murine hind
limb ischemia-reperfusion (IR) injury using the monoclonal antihistone H2A/H2B/DNA complex antibody. A,Wild-
type (WT) tissue sections show extensive immunostaining for NETs (brown) in interstitial tissue (arrowhead) and in
thrombi (arrow) within vessels. There is increased cellular density in regions of intense NETS detection. B, Tissue
section from Toll-like receptor-4 mutant (TLR4m) mice shows minimal if any interstitial (arrowhead) and intravascular
NETs (arrow) immunostaining. C, Contralateral hind limb muscle ﬁbers are normal, with positive immunostaining
only in the nuclei of muscle ﬁbers. D, Negative control. The black bar in each image represents 200 mm.
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Fig 5. Inducible nitric oxide synthase (iNOS) messenger RNA (mRNA) expression is seen in ischemia-reperfusion
(IR) injured murine skeletal muscles using semi-quantitative reverse-transcription polymerase chain reaction. A,
Toll-like receptor-4 mutant (TLR4m) mice had signiﬁcantly less iNOS mRNA expression than wild-type (WT) mice
(*P < .03) normalized to b-actin. B, A representative image of the agarose gel shows the iNOS and b-actin bands from
the two groups of tissue samples.
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the CXC cytokine KC compared with WT serum samples;
however, this did not reach statistical difference (62 6 9 vs
88 6 32 pg/mL, respectively; P ¼ .08; Fig 7, A). In
contrast, serum MCP-1 levels in the TLR4m group were
signiﬁcantly lower than the WT group (TLR4, 98 6 7 vs
WT, 257 6 18 pg/mL; n ¼ 6; P < .0002; Fig 7, B). In
addition, TLR4m mice had signiﬁcantly higher levels of the
proangiogenic factor VEGF (TLR, 1272 6 377 vs WT,
54 6 4 pg/mL; n ¼ 6; P < .015; Fig 7, C). There were no
detectable levels of KC, MCP-1, or VEGF in the serum of
nonischemic WT and TLR4m mice. These data suggest
that the WT group demonstrates a state of greater systemic
inﬂammation than the TLR4m group. Moreover, the
higher levels of VEGF detected in the TLR4m mice may
result from the greater viable tissue remaining in the hind
limb that is attempting to heal itself.
DISCUSSION
These data are the ﬁrst to implicate a role for TLR4 and
NETs in skeletal muscle IR injury. To date, the TLR family
of proteins has been shown to play a pivotal role in medi-
ating venous thrombosis and IR injury in the heart and
brain.1,4,21 In the studies in this report, skeletal muscle ﬁber
injury was signiﬁcantly reduced in TLR4m mice compared
with the WT mice (Fig 1). The decreased level of muscleﬁber injury in the TLR4m group suggests that the ensuing
intense inﬂammation in the WT group likely plays a signiﬁ-
cant role in enhancing the level of tissue injury. It is unclear
whether this increased injury is a direct result of NF-kB
pathway activity, which is known to induce proinﬂammatory
and proapoptotic genes22 or is a secondary effect of the
innate immune system resulting from leukocyte inﬁltration.
An analysis of the extent of inﬂammatory cell inﬁltra-
tion in reperfused skeletal muscle revealed that the de-
creased muscle ﬁber injury in the TLR4m group was
associated with substantially less inﬁltration of MPO-
positive inﬂammatory cells (Fig 2). This observation of
decreased MPO-positive cell inﬁltration with decreased
tissue injury is consistent with experiments geared toward
neutrophil depletion in models of myocardial and small
intestine IR.23,24 TLR4m mice also had substantially less
accumulation of NETs upon reperfusion. Although NETs
have been previously associated with cystic ﬁbrosis,25
venous thrombosis,9 bacterial sepsis,16 and cell death,8
this is the ﬁrst demonstration that NETs are present in
reperfused skeletal muscle. Because the accumulation of
leukocytes in the injured muscle tissue corresponded to
a marked detection of NETs, this strongly suggests that
neutrophils are the most likely source of NETs in the
injured muscle tissue; this is consistent with previous
work demonstrating neutrophils as the dominant source
Fig 6. A, Relative detection of p65 nuclear factor (NF)-kb activity using an enzyme-linked immunosorbent assay is
shown in murine hind limb muscle tissue after ischemia-reperfusion (IR). Toll-like receptor-4 mutant (TLR4m) mice
had less p65 NF-kb activity than wild-type (Wt) mice after 1.5 hours of ischemia and 1 hour of reperfusion (*P ¼
.0025). By 48 hours there was no difference in p65 NF-kb activity detected between the two groups. B, Protein levels
of the a-subunit of inhibitor of NF-kB light polypeptide gene enhancer (IkBa) were quantitated using a Western blot
analysis after 1.5 hours of ischemia and 1 hour of reperfusion. TLR4m mice had signiﬁcantly greater levels of total IkBa
in reperfused skeletal muscle than Wt mice (*P < .01). In contrast, there was no signiﬁcant difference in the Ser32-
phosphorylation of IkBa. C, Representative Western blot analysis of three Wt and three TLR4m-derived muscle
tissues. D, TLR4m mice showed signiﬁcant decrease in the poly adenosine diphosphate ribose-modiﬁed (PAR)
proteins at 48 hours’ reperfusion compared with Wt (*P ¼ .032). E, Representative Western blot image of the detected
poly ADP ribose-modiﬁed proteins in three Wt and three TLR4m skeletal muscle tissues.
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the inﬂammatory response directly by acting on TLRs or
by histone-mediated mechanisms. Extracellular histones
have been shown to produce pathologic responses seen in
sepsis, such as cellular inﬁltration, endothelial cell dysfunc-
tion, thrombosis, and organ failure. TLR2 and TLR4
proteins were recently shown to mediate the sepsis-like
response seen in extracellular histones, and these histones
were shown to activate platelets contributing to the devel-
opment of microvascular thrombosis.12,27-29
To determine whether DNase treatment, which is
currently marketed as Pulmozyme (Genentech Inc, South
San Francisco, Calif) used to treat NETs associated with
cystic ﬁbrosis,30 could destroy NETs in skeletal muscle,
DNase was directly added to the surface of mounted slides
of WT reperfused skeletal muscle. DNase completely
depleted the NETs signal from detection in this ex vivotechnique. This ﬁnding will prompt future exploration of
the potential effectiveness of DNase therapy in an in vivo
model of hind limb IR.
The effects of the TLR4m on skeletal muscle IR were
not limited to the inﬂammatory cells. TLR4m mice had
increased preservation of skeletal muscle high-energy
phosphate levels (Fig 1, D). This ﬁnding is also consistent
with ﬁndings of ethyl pyruvate as a treatment for skeletal
muscle IR.31 TLR4m mice had markedly decreased levels
of iNOS mRNA expression, which is also consistent with
decreased activation of macrophages in other models of
inﬂammation.32,33 The decreased activation of the
NF-kb pathway indicates that the TLR4 receptor
MyD88-dependent pathway likely modulates the NF-kB
pathway activity during reperfusion injury. As expected,
the decrease in NF-kB expression was associated with
increased IkBa expression, which suggests that the decrease
Fig 7. Quantitation of systemic markers of inﬂammation: (A)
keratinocyte-derived cytokine (KC), (B) monocyte chemotactant
protein-1 (MCP-1), and (C) vascular endothelial growth factor
(VEGF). A, Toll-like receptor-4 mutant (TLR4m) and wild-type
(WT) mice had similar levels of the CXC cytokine KC. B, Serum
MCP-1 levels in TLR4m mice, in contrast, were signiﬁcantly lower
than in WT mice after 48 hours of reperfusion (*P ¼ .0002). C,
TLR4m mice also demonstrated a signiﬁcantly higher level of the
proangiogenic factor VEGF (*P ¼ .015).
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suggest the speciﬁcity of decreased cellular stress in the
TLR4m mice subjected to hind limb IR was the observed
decrease in PARP activation. A previous report from
our laboratory using pharmacologic interventions in a clini-
cally relevant post hoc scenario showed only a transient
decrease in PARP activity at 7 hours of reperfusion,34whereas in this report, a signiﬁcant decrease in PARP
activity was observed even at 48 hours of reperfusion.
TLR4m mice had substantially decreased systemic
levels of the proinﬂammatory cytokine, MCP-1, but not
KC. MCP-1 deﬁciency has been shown to alter skeletal
muscle healing,35 and thus, it is not clear that its reduction
in the TLR4m is beneﬁcial. MCP-1, like interleukin-6,
may possibly have proinﬂammatory and anti-inﬂammatory
properties at different times in a physiologic process. In
contrast to decreased MCP-1, circulating levels of VEGF
were increased in the TLR4m group. This may mean
that inhibiting the activity of TLR4 may potentiate postis-
chemic angiogenic pathways.
Our study has several limitations. The use of pharma-
cologic inhibitors of TLR4 or its downstream intracellular
signaling proteins would provide more information on
the potential for clinically targeting TLR4.36-38 Further-
more, it is not clear that the presence of NETs is delete-
rious or cytoprotective. This issue may be further studied
by intravenous or intraperitoneal nuclease treatment,
such as DNase-1, to degrade NETs. IR injury in MPO
or nicotinamide adenine dinucleotide phosphate hydrogen
oxidase knockout mice,39,40 which are known to be deﬁ-
cient in the production of NETs, may also help demon-
strate the potential role NETs may play in IR injury.
CONCLUSIONS
We show that IR injury in the murine hind limb is
modulated by a functional TLR4, suggesting that its inhi-
bition before interventions in acute limb ischemia may be
a potential strategy to minimize IR injury in patients.
This increased muscle ﬁber injury is associated with marked
inﬁltration of neutrophils and marked detection of NETs
in the injured tissue. It is possible that NETs further in-
tensify the hind limb muscle injury given the known
deleterious effects of histones. Although ex vivo nuclease
pretreatment of the hind limb muscle tissue sections dimin-
ishes the level of NET detection, it remains to be shown
whether in vivo nuclease treatment will ameliorate IR
injury in the hind limb muscle tissue.
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